Halozyme Therapeutics (HALO) Short-term Investments (2013 - 2026)
Halozyme Therapeutics' Short-term Investments was $67.87 million in Q2 2026, down 86.0% from $486.32 million a year earlier but up 664.8% from the prior quarter.
Halozyme Therapeutics (HALO) Short-term Investments (2013 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at Halozyme Therapeutics came in at $9 million, down 98.1% from FY2024.
- Short-term Investments shows a five-year compound annual growth rate of -47.2% (FY2020 to FY2025).
- In earlier years, Short-term Investments was $480.22 million in FY2024 (+120.7%), $217.63 million in FY2023 (+69.2%), $128.6 million in FY2022 (-79.3%) and $622.2 million in FY2021 (+182.4%).
- Quarterly Short-term Investments has moved between $8.87 million (Q1 2026) and $668.31 million (Q1 2022) over five years.
- Compared with a year earlier, Short-term Investments has declined for four straight quarters, with growth averaging 9.0% over the last eight quarters.
- The best year-over-year quarter for Short-term Investments over five years was Q4 2021 (growth of 182.4%); the worst was Q1 2026 (a decline of 98.4%).
- Per Business Quant data, HALO's Short-term Investments in the three quarters before Q2 2026 was $8.87 million (Q1 2026), $9 million (Q4 2025) and $282.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Halozyme Therapeutics | 11.73 Bn | 9.97 Bn | 410.50 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 44.40 Mn |
| Jun 30, 2026 | 67.87 Mn |
| Mar 31, 2026 | 8.87 Mn |
| Dec 31, 2025 | 9.00 Mn |
| Sep 30, 2025 | 282.30 Mn |
| Jun 30, 2025 | 486.32 Mn |
| Mar 31, 2025 | 571.59 Mn |
| Dec 31, 2024 | 480.22 Mn |
| Sep 30, 2024 | 511.99 Mn |
| Jun 30, 2024 | 341.17 Mn |
| Mar 31, 2024 | 298.82 Mn |
| Dec 31, 2023 | 217.63 Mn |
| Sep 30, 2023 | 209.06 Mn |
| Jun 30, 2023 | 127.11 Mn |
| Mar 31, 2023 | 179.23 Mn |
| Dec 31, 2022 | 128.60 Mn |
| Sep 30, 2022 | 118.43 Mn |
| Jun 30, 2022 | 118.43 Mn |
| Mar 31, 2022 | 668.31 Mn |
| Dec 31, 2021 | 622.20 Mn |
Halozyme Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=HALO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();